ES2216070T3 - Clonacion molecular y caracterizacion de moleculas relacionadas con la relaxina y la familia de ligandos de insulina. - Google Patents

Clonacion molecular y caracterizacion de moleculas relacionadas con la relaxina y la familia de ligandos de insulina.

Info

Publication number: ES2216070T3
Authority: ES; Spain
Prior art keywords: relaxin; factor; related factor; vector; antibody
Prior art date: 1995-11-03
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

ES96937801T

Other languages

English (en)

Spanish (es)

Inventor

Samuel Davis

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Regeneron Pharmaceuticals Inc

Original Assignee

Regeneron Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-11-03

Filing date

1996-11-01

Publication date

2004-10-16

1996-11-01 Application filed by Regeneron Pharmaceuticals Inc filed Critical Regeneron Pharmaceuticals Inc

2004-10-16 Application granted granted Critical

2004-10-16 Publication of ES2216070T3 publication Critical patent/ES2216070T3/es

2016-11-01 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Links

108090000103 Relaxin Proteins 0.000 title claims abstract description 138
102000003743 Relaxin Human genes 0.000 title claims abstract description 137
108090001061 Insulin Proteins 0.000 title abstract description 21
102000004877 Insulin Human genes 0.000 title abstract description 19
239000003446 ligand Substances 0.000 title abstract description 11
238000012512 characterization method Methods 0.000 title abstract description 7
238000010369 molecular cloning Methods 0.000 title abstract description 7
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title description 24
229940125396 insulin Drugs 0.000 title description 12
108090000623 proteins and genes Proteins 0.000 claims abstract description 39
238000000034 method Methods 0.000 claims abstract description 31
150000007523 nucleic acids Chemical class 0.000 claims abstract description 20
108020004707 nucleic acids Proteins 0.000 claims abstract description 19
102000039446 nucleic acids Human genes 0.000 claims abstract description 19
102000004169 proteins and genes Human genes 0.000 claims abstract description 18
241001465754 Metazoa Species 0.000 claims abstract description 11
239000008194 pharmaceutical composition Substances 0.000 claims abstract description 6
102000009786 Immunoglobulin Constant Regions Human genes 0.000 claims abstract 2
108010009817 Immunoglobulin Constant Regions Proteins 0.000 claims abstract 2
210000004027 cell Anatomy 0.000 claims description 48
230000014509 gene expression Effects 0.000 claims description 20
239000013598 vector Substances 0.000 claims description 18
238000004519 manufacturing process Methods 0.000 claims description 12
108060003951 Immunoglobulin Proteins 0.000 claims description 6
102000018358 immunoglobulin Human genes 0.000 claims description 6
239000000203 mixture Substances 0.000 claims description 6
239000002253 acid Substances 0.000 claims description 5
239000013612 plasmid Substances 0.000 claims description 4
241000238631 Hexapoda Species 0.000 claims description 3
240000004808 Saccharomyces cerevisiae Species 0.000 claims description 3
238000003745 diagnosis Methods 0.000 claims description 3
210000004962 mammalian cell Anatomy 0.000 claims description 3
241000894006 Bacteria Species 0.000 claims description 2
238000011084 recovery Methods 0.000 claims description 2
125000003275 alpha amino acid group Chemical group 0.000 claims 1
238000012258 culturing Methods 0.000 claims 1
238000002405 diagnostic procedure Methods 0.000 claims 1
239000002773 nucleotide Substances 0.000 abstract description 9
125000003729 nucleotide group Chemical group 0.000 abstract description 8
229940088597 hormone Drugs 0.000 abstract description 5
239000005556 hormone Substances 0.000 abstract description 5
239000003937 drug carrier Substances 0.000 abstract 1
150000001413 amino acids Chemical class 0.000 description 15
235000018102 proteins Nutrition 0.000 description 15
235000001014 amino acid Nutrition 0.000 description 13
229940024606 amino acid Drugs 0.000 description 13
239000012634 fragment Substances 0.000 description 13
239000013604 expression vector Substances 0.000 description 8
210000001550 testis Anatomy 0.000 description 8
108020004414 DNA Proteins 0.000 description 7
239000000523 sample Substances 0.000 description 7
238000001890 transfection Methods 0.000 description 7
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
239000003550 marker Substances 0.000 description 6
210000001519 tissue Anatomy 0.000 description 6
108091028043 Nucleic acid sequence Proteins 0.000 description 5
102000007079 Peptide Fragments Human genes 0.000 description 5
108010033276 Peptide Fragments Proteins 0.000 description 5
238000013459 approach Methods 0.000 description 5
230000035935 pregnancy Effects 0.000 description 5
101000599951 Homo sapiens Insulin-like growth factor I Proteins 0.000 description 4
102100037852 Insulin-like growth factor I Human genes 0.000 description 4
210000004556 brain Anatomy 0.000 description 4
210000004246 corpus luteum Anatomy 0.000 description 4
230000006870 function Effects 0.000 description 4
210000004185 liver Anatomy 0.000 description 4
210000001672 ovary Anatomy 0.000 description 4
108090000765 processed proteins & peptides Proteins 0.000 description 4
241000894007 species Species 0.000 description 4
101001076292 Homo sapiens Insulin-like growth factor II Proteins 0.000 description 3
102100025947 Insulin-like growth factor II Human genes 0.000 description 3
ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 3
238000000636 Northern blotting Methods 0.000 description 3
241000700159 Rattus Species 0.000 description 3
108020004511 Recombinant DNA Proteins 0.000 description 3
239000002671 adjuvant Substances 0.000 description 3
230000001580 bacterial effect Effects 0.000 description 3
230000015572 biosynthetic process Effects 0.000 description 3
238000004587 chromatography analysis Methods 0.000 description 3
238000010367 cloning Methods 0.000 description 3
239000002299 complementary DNA Substances 0.000 description 3
238000001514 detection method Methods 0.000 description 3
230000000694 effects Effects 0.000 description 3
239000000499 gel Substances 0.000 description 3
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 3
229960002743 glutamine Drugs 0.000 description 3
210000004408 hybridoma Anatomy 0.000 description 3
238000002347 injection Methods 0.000 description 3
239000007924 injection Substances 0.000 description 3
238000003780 insertion Methods 0.000 description 3
230000037431 insertion Effects 0.000 description 3
210000002826 placenta Anatomy 0.000 description 3
238000002360 preparation method Methods 0.000 description 3
102000004196 processed proteins & peptides Human genes 0.000 description 3
210000002307 prostate Anatomy 0.000 description 3
210000002027 skeletal muscle Anatomy 0.000 description 3
238000012360 testing method Methods 0.000 description 3
238000010361 transduction Methods 0.000 description 3
230000026683 transduction Effects 0.000 description 3
210000004291 uterus Anatomy 0.000 description 3
BJRCFZKVYNDCJE-WBSNEMHCSA-N 99489-95-9 Chemical compound C([C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@H](C(N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N2)[C@@H](C)CC)=O)CSSC[C@@H](C(NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@H](NC1=O)C(O)=O)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O)[C@@H](C)CC)[C@@H](C)CC)C(C)C)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@@H](N)CCCCN)C(C)C)[C@@H](C)CC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CCCNC(N)=N)C(C)C)C1=CC=C(O)C=C1 BJRCFZKVYNDCJE-WBSNEMHCSA-N 0.000 description 2
108010021809 Alcohol dehydrogenase Proteins 0.000 description 2
238000007900 DNA-DNA hybridization Methods 0.000 description 2
229920002307 Dextran Polymers 0.000 description 2
239000006144 Dulbecco’s modiﬁed Eagle's medium Substances 0.000 description 2
241000588724 Escherichia coli Species 0.000 description 2
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
101710114386 Insulin-like protein Proteins 0.000 description 2
241000124008 Mammalia Species 0.000 description 2
108091034117 Oligonucleotide Proteins 0.000 description 2
241000282898 Sus scrofa Species 0.000 description 2
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
230000004075 alteration Effects 0.000 description 2
125000000539 amino acid group Chemical group 0.000 description 2
238000004458 analytical method Methods 0.000 description 2
210000004102 animal cell Anatomy 0.000 description 2
239000000427 antigen Substances 0.000 description 2
102000036639 antigens Human genes 0.000 description 2
108091007433 antigens Proteins 0.000 description 2
230000004071 biological effect Effects 0.000 description 2
210000001185 bone marrow Anatomy 0.000 description 2
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
210000001638 cerebellum Anatomy 0.000 description 2
210000002808 connective tissue Anatomy 0.000 description 2
230000002950 deficient Effects 0.000 description 2
238000012217 deletion Methods 0.000 description 2
230000037430 deletion Effects 0.000 description 2
238000004520 electroporation Methods 0.000 description 2
239000003102 growth factor Substances 0.000 description 2
210000002216 heart Anatomy 0.000 description 2
238000004128 high performance liquid chromatography Methods 0.000 description 2
238000001727 in vivo Methods 0.000 description 2
230000002608 insulinlike Effects 0.000 description 2
210000004698 lymphocyte Anatomy 0.000 description 2
239000002609 medium Substances 0.000 description 2
238000000520 microinjection Methods 0.000 description 2
229920001184 polypeptide Polymers 0.000 description 2
230000008569 process Effects 0.000 description 2
239000000047 product Substances 0.000 description 2
230000006798 recombination Effects 0.000 description 2
230000001105 regulatory effect Effects 0.000 description 2
210000000813 small intestine Anatomy 0.000 description 2
UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
230000001225 therapeutic effect Effects 0.000 description 2
210000001541 thymus gland Anatomy 0.000 description 2
230000009261 transgenic effect Effects 0.000 description 2
230000014616 translation Effects 0.000 description 2
239000002699 waste material Substances 0.000 description 2
MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
WHTVZRBIWZFKQO-AWEZNQCLSA-N (S)-chloroquine Chemical compound ClC1=CC=C2C(N[C@@H](C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-AWEZNQCLSA-N 0.000 description 1
108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
UFBJCMHMOXMLKC-UHFFFAOYSA-N 2,4-dinitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O UFBJCMHMOXMLKC-UHFFFAOYSA-N 0.000 description 1
108010088751 Albumins Proteins 0.000 description 1
102000007698 Alcohol dehydrogenase Human genes 0.000 description 1
102000002260 Alkaline Phosphatase Human genes 0.000 description 1
108020004774 Alkaline Phosphatase Proteins 0.000 description 1
239000004475 Arginine Substances 0.000 description 1
DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
206010006187 Breast cancer Diseases 0.000 description 1
108091028026 C-DNA Proteins 0.000 description 1
102000008186 Collagen Human genes 0.000 description 1
108010035532 Collagen Proteins 0.000 description 1
241000186216 Corynebacterium Species 0.000 description 1
XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 1
102000053602 DNA Human genes 0.000 description 1
230000007023 DNA restriction-modification system Effects 0.000 description 1
108090000204 Dipeptidase 1 Proteins 0.000 description 1
241000233866 Fungi Species 0.000 description 1
108010001515 Galectin 4 Proteins 0.000 description 1
102100039556 Galectin-4 Human genes 0.000 description 1
108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
108700039691 Genetic Promoter Regions Proteins 0.000 description 1
239000004471 Glycine Substances 0.000 description 1
108091005904 Hemoglobin subunit beta Proteins 0.000 description 1
101001091088 Homo sapiens Prorelaxin H2 Proteins 0.000 description 1
XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
239000004472 Lysine Substances 0.000 description 1
241000699666 Mus <mouse, genus> Species 0.000 description 1
241000699670 Mus sp. Species 0.000 description 1
101710107068 Myelin basic protein Proteins 0.000 description 1
241001045988 Neogene Species 0.000 description 1
239000004677 Nylon Substances 0.000 description 1
108700026244 Open Reading Frames Proteins 0.000 description 1
241000283973 Oryctolagus cuniculus Species 0.000 description 1
238000012408 PCR amplification Methods 0.000 description 1
108010067372 Pancreatic elastase Proteins 0.000 description 1
108090000526 Papain Proteins 0.000 description 1
241000237988 Patellidae Species 0.000 description 1
229930182555 Penicillin Natural products 0.000 description 1
JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
102000057297 Pepsin A Human genes 0.000 description 1
108090000284 Pepsin A Proteins 0.000 description 1
102000015731 Peptide Hormones Human genes 0.000 description 1
108010038988 Peptide Hormones Proteins 0.000 description 1
108091000080 Phosphotransferase Proteins 0.000 description 1
241000276498 Pollachius virens Species 0.000 description 1
ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
102100034949 Prorelaxin H2 Human genes 0.000 description 1
239000004365 Protease Substances 0.000 description 1
101150030952 RRF1 gene Proteins 0.000 description 1
241000714474 Rous sarcoma virus Species 0.000 description 1
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
238000002105 Southern blotting Methods 0.000 description 1
101000857870 Squalus acanthias Gonadoliberin Proteins 0.000 description 1
101100417964 Streptococcus mutans serotype c (strain ATCC 700610 / UA159) frr gene Proteins 0.000 description 1
241000282887 Suidae Species 0.000 description 1
240000002871 Tectona grandis Species 0.000 description 1
108020005038 Terminator Codon Proteins 0.000 description 1
AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
239000004473 Threonine Substances 0.000 description 1
102000006601 Thymidine Kinase Human genes 0.000 description 1
108020004440 Thymidine kinase Proteins 0.000 description 1
QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
241000700605 Viruses Species 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
230000009471 action Effects 0.000 description 1
239000013543 active substance Substances 0.000 description 1
235000004279 alanine Nutrition 0.000 description 1
108010050122 alpha 1-Antitrypsin Proteins 0.000 description 1
WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
230000000692 anti-sense effect Effects 0.000 description 1
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
235000009582 asparagine Nutrition 0.000 description 1
229960001230 asparagine Drugs 0.000 description 1
235000003704 aspartic acid Nutrition 0.000 description 1
235000019606 astringent taste Nutrition 0.000 description 1
210000003719 b-lymphocyte Anatomy 0.000 description 1
OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
102000006635 beta-lactamase Human genes 0.000 description 1
230000003115 biocidal effect Effects 0.000 description 1
230000008512 biological response Effects 0.000 description 1
230000036772 blood pressure Effects 0.000 description 1
210000000481 breast Anatomy 0.000 description 1
210000004899 c-terminal region Anatomy 0.000 description 1
238000004113 cell culture Methods 0.000 description 1
230000001413 cellular effect Effects 0.000 description 1
230000008859 change Effects 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
239000003638 chemical reducing agent Substances 0.000 description 1
230000035606 childbirth Effects 0.000 description 1
229960003677 chloroquine Drugs 0.000 description 1
WHTVZRBIWZFKQO-UHFFFAOYSA-N chloroquine Natural products ClC1=CC=C2C(NC(C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-UHFFFAOYSA-N 0.000 description 1
-1 cistern Chemical compound 0.000 description 1
238000003776 cleavage reaction Methods 0.000 description 1
229920001436 collagen Polymers 0.000 description 1
230000000052 comparative effect Effects 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
238000010276 construction Methods 0.000 description 1
125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 1
210000003785 decidua Anatomy 0.000 description 1
238000000502 dialysis Methods 0.000 description 1
230000029087 digestion Effects 0.000 description 1
230000010339 dilation Effects 0.000 description 1
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical group P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
238000009826 distribution Methods 0.000 description 1
210000004670 early embryonic cell Anatomy 0.000 description 1
210000002308 embryonic cell Anatomy 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
210000004696 endometrium Anatomy 0.000 description 1
238000010195 expression analysis Methods 0.000 description 1
230000035558 fertility Effects 0.000 description 1
239000012530 fluid Substances 0.000 description 1
238000009472 formulation Methods 0.000 description 1
230000002538 fungal effect Effects 0.000 description 1
102000037865 fusion proteins Human genes 0.000 description 1
108020001507 fusion proteins Proteins 0.000 description 1
238000002523 gelfiltration Methods 0.000 description 1
238000012239 gene modification Methods 0.000 description 1
230000002068 genetic effect Effects 0.000 description 1
230000005017 genetic modification Effects 0.000 description 1
235000013617 genetically modified food Nutrition 0.000 description 1
230000013595 glycosylation Effects 0.000 description 1
238000006206 glycosylation reaction Methods 0.000 description 1
108060003552 hemocyanin Proteins 0.000 description 1
210000003630 histaminocyte Anatomy 0.000 description 1
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
230000006801 homologous recombination Effects 0.000 description 1
238000002744 homologous recombination Methods 0.000 description 1
230000002209 hydrophobic effect Effects 0.000 description 1
238000004191 hydrophobic interaction chromatography Methods 0.000 description 1
210000003016 hypothalamus Anatomy 0.000 description 1
230000028993 immune response Effects 0.000 description 1
230000016784 immunoglobulin production Effects 0.000 description 1
229940072221 immunoglobulins Drugs 0.000 description 1
239000007943 implant Substances 0.000 description 1
238000002513 implantation Methods 0.000 description 1
238000000338 in vitro Methods 0.000 description 1
210000003000 inclusion body Anatomy 0.000 description 1
208000015181 infectious disease Diseases 0.000 description 1
230000005764 inhibitory process Effects 0.000 description 1
229910052500 inorganic mineral Inorganic materials 0.000 description 1
238000001361 intraarterial administration Methods 0.000 description 1
230000004410 intraocular pressure Effects 0.000 description 1
238000007912 intraperitoneal administration Methods 0.000 description 1
238000007913 intrathecal administration Methods 0.000 description 1
238000001990 intravenous administration Methods 0.000 description 1
238000004255 ion exchange chromatography Methods 0.000 description 1
AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
229960000310 isoleucine Drugs 0.000 description 1
230000035800 maturation Effects 0.000 description 1
239000012528 membrane Substances 0.000 description 1
MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
229930182817 methionine Natural products 0.000 description 1
239000011707 mineral Substances 0.000 description 1
230000035772 mutation Effects 0.000 description 1
210000000066 myeloid cell Anatomy 0.000 description 1
108010065781 myosin light chain 2 Proteins 0.000 description 1
101150091879 neo gene Proteins 0.000 description 1
230000007935 neutral effect Effects 0.000 description 1
229920001778 nylon Polymers 0.000 description 1
238000011275 oncology therapy Methods 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
230000016087 ovulation Effects 0.000 description 1
210000000496 pancreas Anatomy 0.000 description 1
229940055729 papain Drugs 0.000 description 1
235000019834 papain Nutrition 0.000 description 1
229940049954 penicillin Drugs 0.000 description 1
229940111202 pepsin Drugs 0.000 description 1
239000000813 peptide hormone Substances 0.000 description 1
230000000144 pharmacologic effect Effects 0.000 description 1
COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
239000002953 phosphate buffered saline Substances 0.000 description 1
108010079892 phosphoglycerol kinase Proteins 0.000 description 1
102000020233 phosphotransferase Human genes 0.000 description 1
210000005059 placental tissue Anatomy 0.000 description 1
239000013600 plasmid vector Substances 0.000 description 1
229920001983 poloxamer Polymers 0.000 description 1
229920000447 polyanionic polymer Polymers 0.000 description 1
229920005862 polyol Polymers 0.000 description 1
150000003077 polyols Chemical class 0.000 description 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
230000009465 prokaryotic expression Effects 0.000 description 1
230000002797 proteolythic effect Effects 0.000 description 1
210000004061 pubic symphysis Anatomy 0.000 description 1
238000003259 recombinant expression Methods 0.000 description 1
238000005215 recombination Methods 0.000 description 1
230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
238000007634 remodeling Methods 0.000 description 1
230000003362 replicative effect Effects 0.000 description 1
230000037195 reproductive physiology Effects 0.000 description 1
238000012552 review Methods 0.000 description 1
230000007017 scission Effects 0.000 description 1
230000035939 shock Effects 0.000 description 1
230000016160 smooth muscle contraction Effects 0.000 description 1
230000019100 sperm motility Effects 0.000 description 1
238000010186 staining Methods 0.000 description 1
229960005322 streptomycin Drugs 0.000 description 1
238000007920 subcutaneous administration Methods 0.000 description 1
239000006228 supernatant Substances 0.000 description 1
238000013268 sustained release Methods 0.000 description 1
239000012730 sustained-release form Substances 0.000 description 1
229940034208 thyroxine Drugs 0.000 description 1
XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 1
230000002103 transcriptional effect Effects 0.000 description 1
230000009466 transformation Effects 0.000 description 1
238000013519 translation Methods 0.000 description 1
241000701161 unidentified adenovirus Species 0.000 description 1
239000004474 valine Substances 0.000 description 1
230000002792 vascular Effects 0.000 description 1
210000003501 vero cell Anatomy 0.000 description 1
238000001262 western blot Methods 0.000 description 1
210000005253 yeast cell Anatomy 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/64—Relaxins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Endocrinology (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Biochemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Gastroenterology & Hepatology (AREA)
Genetics & Genomics (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Toxicology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Biophysics (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

ES96937801T 1995-11-03 1996-11-01 Clonacion molecular y caracterizacion de moleculas relacionadas con la relaxina y la familia de ligandos de insulina. Expired - Lifetime ES2216070T3 (es)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date
US622195P	1995-11-03	1995-11-03
US6221P		1995-11-03
US1201696P	1996-02-21	1996-02-21
US12016P		1996-02-21

Publications (1)

Publication Number	Publication Date
ES2216070T3 true ES2216070T3 (es)	2004-10-16

Family

ID=26675338

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ES96937801T Expired - Lifetime ES2216070T3 (es)	1995-11-03	1996-11-01	Clonacion molecular y caracterizacion de moleculas relacionadas con la relaxina y la familia de ligandos de insulina.

Country Status (10)

Country	Link
EP (1)	EP0866861B1 (de)
JP (1)	JPH11514524A (de)
AT (1)	ATE260340T1 (de)
AU (1)	AU713773B2 (de)
CA (1)	CA2236297A1 (de)
DE (1)	DE69631678T2 (de)
DK (1)	DK0866861T3 (de)
ES (1)	ES2216070T3 (de)
PT (1)	PT866861E (de)
WO (1)	WO1997016549A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU3972797A (en) *	1996-08-02	1998-02-25	Zymogenetics Inc.	Testis-specific insulin homolog polypeptides
US6709659B1 (en)	1996-08-02	2004-03-23	Zymogenetics, Inc.	Antibodies that bind testis-specific insulin homolog polypeptides
US6046028A (en) *	1996-10-15	2000-04-04	Zymogenetics, Inc.	Polynucleotides encoding insulin homolog zins3
AU5530198A (en) *	1996-12-16	1998-07-15	Zymogenetics Inc.	Compositions and methods for stimulating pancreatic islet cell regeneration
US20050032683A1 (en)	2000-10-04	2005-02-10	Amento Edward P.	Methods of modulating apoptosis by administration of relaxin agonists or antagonists
AU2012280474A1 (en)	2011-07-01	2014-01-16	Bayer Intellectual Property Gmbh	Relaxin fusion polypeptides and uses thereof
WO2013090318A1 (en) *	2011-12-12	2013-06-20	Trustees Of Boston University	Utility of insulin-like 6 (insl6) for the treatment of autoimmune diseases
CN115837014A (zh) *	2016-05-18	2023-03-24	摩登纳特斯有限公司	编码松弛素的多核苷酸

1996
- 1996-11-01 WO PCT/US1996/017342 patent/WO1997016549A2/en not_active Ceased
- 1996-11-01 ES ES96937801T patent/ES2216070T3/es not_active Expired - Lifetime
- 1996-11-01 AT AT96937801T patent/ATE260340T1/de not_active IP Right Cessation
- 1996-11-01 AU AU75261/96A patent/AU713773B2/en not_active Ceased
- 1996-11-01 DK DK96937801T patent/DK0866861T3/da active
- 1996-11-01 JP JP9517490A patent/JPH11514524A/ja active Pending
- 1996-11-01 DE DE1996631678 patent/DE69631678T2/de not_active Expired - Fee Related
- 1996-11-01 EP EP96937801A patent/EP0866861B1/de not_active Expired - Lifetime
- 1996-11-01 CA CA002236297A patent/CA2236297A1/en not_active Abandoned
- 1996-11-01 PT PT96937801T patent/PT866861E/pt unknown

Also Published As

Publication number	Publication date
AU7526196A (en)	1997-05-22
EP0866861A2 (de)	1998-09-30
JPH11514524A (ja)	1999-12-14
PT866861E (pt)	2004-05-31
CA2236297A1 (en)	1997-05-09
EP0866861B1 (de)	2004-02-25
WO1997016549A2 (en)	1997-05-09
DE69631678D1 (de)	2004-04-01
DE69631678T2 (de)	2005-01-13
DK0866861T3 (da)	2004-06-21
AU713773B2 (en)	1999-12-09
ATE260340T1 (de)	2004-03-15
WO1997016549A3 (en)	1997-06-19

Publication	Publication Date	Title
JP6634402B2 (ja)	2020-01-22	代謝障害及び疾患の治療のための組成物、使用及び方法
CA2211687C (en)	2011-05-24	Vascular endothelial growth factor-b
Pelton et al.	1991	Immunohistochemical localization of TGF beta 1, TGF beta 2, and TGF beta 3 in the mouse embryo: expression patterns suggest multiple roles during embryonic development.
JP4943410B2 (ja)	2012-05-30	線維芽細胞増殖因子様ポリペプチド
JP4181300B2 (ja)	2008-11-12	改変された、背側組織に影響する因子および組成物
CA2404945C (en)	2010-02-09	Taci as an anti-tumor agent
US7070774B2 (en)	2006-07-04	Antibodies that bind testis-specific insulin homolog polypeptides
PT93996B (pt)	1997-09-30	Processo para a producao de factor de crescimento de celulas endoteliais vasculares e de dna codificador do mesmo
KR100334739B1 (ko)	2002-09-17	절단된신경교세포주-유래신경영양성인자단백질산물
JPH074249B2 (ja)	1995-01-25	インシユリン受容体
JP2012530493A (ja)	2012-12-06	キメラポリペプチドおよびその使用
US20120189634A1 (en)	2012-07-26	Taci as an anti-tumor agent
JP2002526073A (ja)	2002-08-20	新規のヒト生長分化因子のコード配列、そのｄｎａ配列によりコードされるポリペプチド、およびこれらの製造方法。
PT92603B (pt)	1995-09-12	Processo de producao de factor de crescimento transformante, quimerico,beta
EP0630404A1 (de)	1994-12-28	Protein, die das tumorwachstum inhibieren kann
TW200427472A (en)	2004-12-16	Device comprising VGF polypeptides
EP0866861B1 (de)	2004-02-25	Molekulare klonierung und charakterisierung von molekülen, welche verwandt sind mit relaxin und liganden der insulinfamilie
US6469139B1 (en)	2002-10-22	Modified human chorionic gonadotropin (β-hCG) proteins and their medical use
JP2001522589A (ja)	2001-11-20	ミエリン乏突起膠細胞糖タンパク質ファミリーの新規タンパク質メンバーである、ｂｍｏｇおよびその免疫調節目的のための使用
US7317095B2 (en)	2008-01-08	Mutant glycoproteins
EP0728012B1 (de)	2004-02-18	NEUARTIGE GnRH - ANALOGE MIT ANTITUMORALEN EFFEKTEN UND SIE ENTHALTENDE PHARMAZEUTISCHE ZUBEREITUNGEN
EP1746106A2 (de)	2007-01-24	Verwendung von TACI als Antitumormittel
JP2002508170A (ja)	2002-03-19	哺乳動物カルシトニン様ポリペプチド−１
Rao	1996	Brondyk et a
AU3766593A (en)	1993-10-05	Protein compound capable of inhibiting tumoral growth